Category:

GENERAL

• • •

• • •

SFDA Expands Lojuxta Indication to Include Treatment of Children with Homozygous Familial Hypercholesterolemia

Riyadh: The Saudi Food and Drug Authority (SFDA) announced its approval of a new medical claim for Lojuxta (lomitapide), allowing its use to treat children aged five years and older diagnosed with Homozygous Familial Hypercholesterolemia (HoFH). This approval positions SFDA as the first regulatory authority worldwide to authorize the pediatric

• • • Read More • • •

Fashion Commission Concludes ‘Saudi Heritage Revival: Arts and Handcrafts’ Initiative in Collaboration with Swarovski

Riyadh: The Fashion Commission has successfully concluded its “Saudi Heritage Revival: Arts and Handcrafts” initiative, a program designed to revive traditional Saudi handcrafts and empower emerging designers through hands-on training and creative development. Hosted at FCR (Future Creative Residence), the commission’s creative space, the initiative aligns with national efforts to

• • • Read More • • •

RECENT POSTS